Next-Generation Sequencing

NGS and analysis: All in a single kit

Targeted NGS panels and optimized analysis and interpretation tools

NGS can be challenging – overcome the bottlenecks you face with the help of our single kit solution. We’ve combined the precision of our QIAseq DNA Panels with intuitive bioinformatics tools to create a single unified solution so you can detect low-frequency variants and analyze your NGS data with confidence. QIAseq DNA panels now include subscription licenses for CLC Genomics Workbench and QIAGEN Clinical Insight (QCI)-Interpret for QIAseq software, so you can make the leap from generating data to accumulating insights with greater ease and speed. Learn more here.

“Large-scale genomic information is accelerating scientific progress. Storing, analyzing and managing these data is becoming a critical challenge for researchers.“

Eric Lander, President and Director of the Broad Institute¹

Superior solutions for every step of the workflow

Try our integrated solution

Get in touch to discover how our integrated solution can help you advance your research.

Available QIAseq DNA Panels

Somatic Cancer Panels	Hereditary Cancer Panels	Hereditary Disease Panels
Myeloid Neoplasms Lung Cancer Actionable Solid Tumor Comprehensive Cancer Tumor Mutational Burden	Breast Cancer Colorectal Cancer BRCA1 and BRCA2 BRCA1 and BRCA2 Plus	Pharmacogenomics Mitochondria Inherited Disease

Learn more about QIAseq DNA Panels.

QIAseq DNA Custom Panels

Create your own QIAseq DNA Custom Panels, which can be tailored to target exonic regions of genes, hotspots or SNPs, as well as intronic and promoter regions. Use the free, online QIAseq Targeted DNA Custom Panel Builder tool to select from RefSeq the genomic regions you wish to target, or upload your own custom target list. Access the tool and browse other valuable molecular solutions in the GeneGlobe Design and Analysis Hub.

Learn more

QIAseq Targeted DNA Extended Panels

In addition to QIAseq custom panels, you can also create QIAseq Targeted DNA Extended Panels, which allow you to extend the content of any of the cataloged panels by adding up to 100 new primers.

Learn more

Insight makes the difference

QIAseq DNA Panel kits don’t just deliver superior sequencing coverage and a faster workflow — they also provide the tools you need to gain knowledge from results, using QCI-Interpret for QIAseq software. Supporting more than 1000 laboratories and professionals worldwide, the cloud-based QCI platform provides all the capabilities required to transform complex NGS data into insights, in an easy-to-understand sample report.

Discover novel findings more quickly
Access comprehensive variant information
Use tailored workflows for multiple applications

Check out an example report here.

Testimonials

Learn what our customers are saying about our QIAseq DNA panels and our bioinformatics solutions for analysis and interpretation of NGS data.

Fast and easy sequencing data interpretation.

Anna Stittrich, Primary Investigator, Charité Universitätsmedizin Berlin

QCI-I saves a significant amount of time, especially for panels without common pathogenic variants.

Dr. Ansreas Rump, Institute for Clinical Genetics at Technical University Dresden

The CLC Genomics software is easy to learn and use. No need to have an extensive knowledge of computer languages to be able to analyze NGS data.

Primary Investigator, Federal Government

"For researchers to be able to analyze very large numbers of samples at the same time, we needed a strategy which was high-throughput and cost-effective. We are running 800 samples a week in batch mode and analyzing them across 38 genes, all with the help of the QIAseq panels."

Dr. Fergus Couch, Mayo Clinic

Watch the full movie here

¹ Eric Lander, president and director of the Broad Institute (2015, June 24) Researchers to use Google cloud to aid in genome analysis. [Press release]. Retrieved from https://www.computerworld.com/article/2940374/researchers-to-use-google-cloud-to-aid-in-genome-analysis.html

The products mentioned here are intended for molecular biology applications. These products are not intended for the diagnosis, prevention, or treatment of a disease.

All photos taken prior to COVID-19